Preoperative CA125 as a prognostic factor in stage I epithelial ovarian cancer

APMIS

Volumn 114, Issue 5, 2006, Pages 359-363

  Petri, Anette Lykke ^a   Høgdall, Estrid ^b   Christensen, Ib Jarle ^c   Kjaer, Susanne Krüger ^a,b   Blaakær, Jan ^d   Høgdall, Claus Kim ^a  

^a Rigshospitalet   (Denmark)

^b INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^c HVIDOVRE HOSPITAL   (Denmark)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Ovarian cancer stage; Preoperative CA125; Prognostic factor

Indexed keywords

CA 125 ANTIGEN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD LEVEL; CANCER GRADING; CANCER PATIENT; CANCER SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HISTOLOGY; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME;

ADULT; AGED; DENMARK; FEMALE; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PROGNOSIS; PROTEINS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 33744783953     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2006.apm_397.x     Document Type: Article

References (11)

1. Kjaerbye-Thygesen A Huusom LD Frederiksen K, et al. Trends in the incidence and mortality of ovarian cancer in Denmark 1978-2002. Comparison with other Nordic countries. Acta Obstet Gynecol Scand 2005 84:1006 12.
2. Petterson F Coppleson M Creasman W, et al. Annual Report on the Results of Treatment in Gynecological Cancer, Vol. 20. Stockholm, Sweden:International Federation of Gynaecology and Obstetrics, 1988:110 51.
3. Trimbos JB Parmar M Vergote I, et al. International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma. J Natl Cancer Inst 2003 95:105 12.
4. Bast RC Jr. Feeney M Lazarus H, et al. Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest 1981 68:1331 37.
5. Paramasivam S Tripcony L Crandon A, et al. Prognostic importance of preoperative CA-125 in International Federation of Gynecology and Obstetrics stage I epithelial ovarian cancer: an Australian multicenter study. J Clin Oncol 2005 23:1 5.
6. Nagele F Petru E Medl M, et al. Preoperative CA 125: an independent prognostic factor in patients with stage I epithelial ovarian cancer. Obstet Gynecol 1995 86:259 64.
7. Høgdall EVS Christensen L Kjaer SK, et al. Distribution of HER-2 overexpression in ovarian carcinoma tissue and its prognostic value in patients with ovarian carcinoma: from the Danish MALOVA Ovarian Cancer Study. Cancer 2003 98:66 73.
8. McGuire WP Weinberg H Weinberg J. CA-125 and early ovarian cancer: does this help the clinician or further muddy the water? J Clin Oncol 2005 23:1 3.
9. Helewa ME Krepart GV Lotocki R. Staging laparotomy in early epithelial ovarian carcinoma. Am J Obstet Gynecol 1986 154:282 6.
10. Young RC. Early-stage ovarian cancer: to treat or not to treat. J Natl Cancer Inst 2003 95:94 5.
11. International Collaborative Ovarian Neoplasm 1 (ICON1) and European Organisation for Research and Treatment of Cancer Collaborators-Adjuvant Chemotherapy In Ovarian Neoplasm (EORTC-ACTION). International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma. J Natl Cancer Inst 2003 95:105 12.